Country/territory-wise SARS-CoV-2 lineage distributions of 13,465,375 genomes from GISAID (up to February 24, 2024) based on the combinations of bases at 206 marker sites and variants of concern (VOCs) defining mutation sites. In total 15,083,368 genomes were retrieved from GISAID (as of February 23, 2024), 13,465,375 genomes were used in the analysis after quality control. Criteria for quality control : 1) Ns < 5%; 2) length > 29,000 after removing Ns.
Estimation of the reproduction number (R) and prediction of the infected population of SARS-CoV-2 for each country by fitting a Susceptible, Un-quanrantined infected, Quarantined infected, Confirmed infected (SUQC) model.
A tool for assigning SARS-CoV-2 genomes into defined lineages based on the combinations of bases at 206 marker sites and variants of concern (VOCs) defining mutation sites.
Summary of global dynamics of COVID-19 pandemic, including the cumulative confirmed cases, daily confirmed cases, active confirmed cases, deaths, and matality for each country.
Visualizing variant sites (29,892 in total, degenerate bases excluded) in 13,465,375 SARS-CoV-2 genomes from GISAID (up to February 24, 2024). Quality control: 1) Ns < 5%; 2) length > 29,000 after removing Ns.